Victory Capital Management Inc Uro Gen Pharma Ltd. Transaction History

Victory Capital Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 07, 2020	SELL	$16.5 - $29.7 $503,662 - $906,592	-30,525 Closed	0 $0
Q1 2020 May 04, 2020	SELL	$13.68 - $34.6 $53,912 - $136,358	-3,941 Reduced 11.43%	30,525 $545,000
Q4 2019 Feb 06, 2020	BUY	$21.11 - $34.86 $82,434 - $136,128	3,905 Added 12.78%	34,466 $1.15 Million
Q4 2019 Feb 04, 2020	SELL	$21.11 - $34.86 $51,803 - $85,546	-2,454 Reduced 7.43%	30,561 $899,000
Q3 2019 Nov 12, 2019	BUY	$23.83 - $36.44 $766,420 - $1.17 Million	32,162 Added 3770.46%	33,015 $787,000
Q4 2018 Feb 05, 2019	SELL	$38.35 - $50.39 $6,212 - $8,163	-162 Reduced 15.96%	853 $37,000
Q3 2018 Nov 01, 2018	BUY	$41.65 - $51.7 $42,274 - $52,475	1,015 New	1,015 $48,000

130

35.9M

22K

93.8K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $260M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.